Bacil Pharma Ltd is in Pharmaceutical businessOperational Status: Company is non operational for the past many years. It has not carried out any major business activity and management is considering diversifying their business activities and have deployed surplus funds as temporary loans and advances
Bacil Pharma Limited's Board has approved two new director appointments. Mr. Mahesh Singh joins as a Non-Executive Independent Director, bringing experience in accounting and financial matters to strengthen the Board. Mr. Anil Shiv Charan Singh has been appointed as a Non-Executive Director, expected to enhance the Board with his expertise...
Bacil Pharma Limited has announced the incorporation of a new wholly-owned subsidiary, BACIL RESEARCH & DEVELOPMENT PRIVATE LIMITED. This strategic move creates a dedicated entity focused on the company's research and development initiatives. For shareholders, this signals an expansion of the company's operational structure, aiming to drive innovation and potentially...
The company's board approved a Rights Issue to raise up to 50 Cr. To enable this, the board also approved increasing the Authorised Share Capital by 45 Cr, bringing the new total to 65 Cr, pending shareholder approval. Intermediaries for the Rights Issue were appointed. Separately, two Independent Directors, Mr....
Bacil Pharma has filed a certificate confirming its share dematerialization processes for the quarter ending June 30. The company's Registrar and Transfer Agent verified that all shares submitted for dematerialization were processed correctly. This includes ensuring dematerialized shares are listed, original physical certificates are cancelled, and depositories are recorded as...
Bacil Pharma's board has approved a Rights Issue to raise up to 50 Cr, aiming to strengthen its financial position and support business growth. To facilitate this fundraise, the board also approved increasing the company's Authorized Share Capital by 45 Cr, bringing the total to 65 Cr, pending shareholder approval....
